InnoStars Awards semi-finalists

´R-nuucell` a spin-off of Faculdade de Ciências da Universidade de Lisboa, founded by M. Helena Garcia and Andreia Valente from CQE Group 4, was selected as one of the semi-finalists of the InnoStars Awards 2021, one of EIT Health`s most competitive accelerator programs.

This year InnoStars Awards counted with 175 applications from which 'R-nuucell' with the RuPharma project, is one of the selected fifteen to participate in the semi-finals.

https://eithealth.eu/news-article/15-new-health-innovations-in-the-innostars-awards-semi-finals/

https://eithealth.eu/news-article/innostars-awards-makes-an-astonishing-comeback/

https://teclabs.pt/spinoffinvestedbypv/

InnoStars Awards is one of EIT Health’s most competitive accelerator programmes, aimed at early-stage start-ups. The semi-finalists will receive €25 000 for business training and mentoring support from world-class experts. The ten best performing teams will get into the finals.

Published/edited: 16/06/2021